AKD's practice houses 'a dedicated team of seasoned experts with broad and deep experience in the healthcare industry'. The client roster includes medical associations, healthcare providers, and pharma companies. Practice co-head Joris Rijken is active in contractual work in the healthcare sector, and is equally adept at assisting with care procurement issues. Practice co-head Barbara Mutsaers, who is based in the Eindhoven office, has 'an extremely high level of knowledge of the industry', with a solid track record in handling work concerning clinical trials, marketing authorisations, administrative proceedings and product liability issues. Marlou Jannink is 'precise and dedicated'. Maartje de Jong left the firm in December 2024.

A&O Shearman‘s 'extremely responsive, competent, and commercial' team is highly regarded for its ability to handle the full spectrum of contentious and non-contentious issues in the life sciences sector. The group is active on matters in the medtech, biotech, and pharma industries. Practice co-head Frits Gerritzen brings expertise in IP litigation, and is well known for his experience in advising on R&D and license agreements, as well as disputes concerning pharma products, antibodies, and medical equipment. Co-head Christiaan De Brauw specialises in corporate law, and often acts for biotech companies and venture capital entities in M&A and investment work. Jort de Groodt is a key contact for life sciences and technology sector matters.

Hogan Lovells International LLP‘s 'very proactive and knowledgeable' team has an excellent reputation for advising clients on a broad range of matters, including orphan designations and domestic and international EU regulatory issues. Practice head Hein van den Bos is particularly skilled at advising on regulatory issues involving pharma companies and healthcare professionals, and is equally strong in assisting with EU marketing authorisation applications and data exclusivity and advertising cases. Gertjan Kuipers is 'a stellar litigator', who is noted for his extensive expertise in patent infringement matters and is well known for appearing in disputes before the European Patent Office (EPO) and the Unified Patent Court (UPC). Bert Oosting retired from practice in February 2024.

Loyens & Loeff is known for handling a broad range of matters in the healthcare and life sciences arena, including advising on clinical trials, investments, procurement cases and competition issues. Kim Lucassen leads the firm's data protection and privacy practice and is active in life sciences and healthcare matters; she co-heads the department with Vincent van der Lans, a key contact for M&A work and multi-jurisdictional restructurings, and the 'highly skilled' Tom van Helmond, who handles a wide spectrum of procurement and competition law issues. Dieuwke Hooft Graafland's 'knowledge of legislation in her field of expertise is remarkable'. Hamza Zourakhti left the firm in September 2024.

Based in The Hague, BarentsKrans' 'very dedicated' team often advises on regulatory disputes, sensitive data matters, and public procurement proceedings. Jaap Bremer heads the practice, and is known for his extensive experience in advising on high-value patent litigation in the pharma sector, as well as handling distribution and license agreements. Competition and public procurement expert Tim Raats continues to act for tenderers in mental healthcare and home care matters, and Annelies van der Ploeg is a key contact for contractual issues. Marc Elshof is well versed in advising on cross-border tech, cybersecurity, and data issues.

The team at Bird & Bird has 'deep legal knowledge combined with a flexible and client-focused approach'. The group is well regarded for it strength in advising on data protection compliance, M&A, large-scale patent infringement cases and exclusivity disputes. Marc van Wijngaarden fields expertise in representing global pharma companies in patent litigation, and co-heads the practice with regulatory expert Hester Borgers, a key contact for digital health matters, and Wilfred Steenbruggen, who handles data work in the healthcare area. Wouter Pors is 'an exceptional advocate', who regularly acts for clients in the biotech industry.

Ellen Gielen and Gertie Lintjens jointly head CMS‘ practice, which is known for advising on M&A, contentious reimbursement matters, and pricing negotiations. The 'very knowledgeable' Gielen has extensive experience in handling regulatory cases, often involving pharmaceutical and medical device issues, while Lintjens is well versed in handling R&D projects and early access matters involving pharma products. Judith Kok has a solid track record in assisting with biocides matters and distribution issues. Murat Duman joined the group in January 2024.

At De Brauw Blackstone Westbroek, the team is well known for appearing before the Dutch Supreme Court in patent cases, and is equally strong in handling investment and refinancing matters. Anne Marie Verschuur and Gaby Smeenk co-head the practice; the former is well versed in handling matters concerning trade secrets, as well as infringement and validity proceedings, while the latter assists with M&A and capital markets transactions. Bertrand Ter Woort is a key contact for medical device and pharma clients, and Stephanie de Beer has established strength in handling patent validity and infringement disputes.

Houthoff‘s practice, which is jointly led by Huib Lebbing and Freeke Heijne, is well known for representing the Ministry of Public Health and other prominent clients in a wide range of healthcare and hospital-focused matters. Lebbing is 'very knowledgeable, with a highly developed analytical mind', and Heijne draws on her public law expertise to advise healthcare providers, insurers, and investors on civil proceedings. Murat Duman left the firm in January 2024.

The practice at NautaDutilh has a solid track record in acting for pharma clients in a broad range of work, including transactional matters, patent proceedings and class action claims relating to medical devices. The 'exceptionally insightful' Ruud Smits is active in transactional work, and advises medical device, pharma, and biotech start-ups and investors on financing matters. Smits co-heads the department with Jeroen Boelens, a key contact for licensing and M&A issues, as well as multi-jurisdictional patent disputes. Paul van der Bijl is a name to note.

Johan Renes, Bas Berghuis van Woortman, and Machteld Hiemstra co-head the practice at Simmons & Simmons, which is well-known for its strength in patent litigation. Renes has longstanding experience in multi-jurisdictional patent disputes, licensing matters and collaboration agreements. Hiemstra is a key name for representing pharma and biotech entities in regulatory and product liability disputes, and van Woortman is noted for his vast experience in representing biosimilar manufacturers in patent-related work. Oscar Lamme is well-versed in assisting with UPC proceedings.

Van Doorne's 'outstanding team of expert lawyers' is very experienced in digital health matters. Willemien Bischot acts for healthcare providers and academic hospitals in a range of corporate matters, as well as assisting elderly and special needs providers; she co-heads the practice with the 'excellent' Dimitri van Hoewijk, who regularly acts as counsel to healthcare institutions. Other key figures restructuring and acquisitions expert Siego Boslooper; Nick Suurmond, who handles joint ventures and investments; and tax specialist Daniëlle Westerhoff.

Dirkzwager legal & tax is perhaps best known for its strong track record in acting for hospitals in the Netherlands in a broad range of healthcare-related matters. Koen Mous is well-versed in handling claims against health insurers, in addition to healthcare contracts, while Marieke van Dongen‘s primary areas of expertise include M&A, restructurings, and governance issues within the healthcare space. Ernst-Jan van de Pas specialises in advising hospitals on IT and tech procurement issues. Louis Houwen is a key contact for hospitals and health providers, and Luuk Arends often represents mental health and elderly care providers. All named practitioners co-head the practice.

Kennedy Van der Laan's practice houses 'an involved team with broad and excellent knowledge'. The group is well versed in handling the full spectrum of transactional issues within the healthcare sector. Practice co-head Fenna van Dijk draws on her corporate law expertise to assist healthcare institutions and medical device suppliers, while co-head Maarten Schut has longstanding experience in assisting with R&D collaborations and license agreements. Other key practitioners include Eline Lam, who advises on collaboration matters in the healthcare sector, and Anne ten Brummelhuis, who counts tariff regulation as a key area of strength.

La Gro's practice has vast experience in assisting with the corporate restructuring of healthcare entities and UPC infringement proceedings. Practice head Marleen van den Horst is well known for handling SPC and regulatory issues, and often acts for large pharmaceutical companies in matters concerning clinical trials and orphan medicinal products. Benjamin Niemeijer has expertise in IP litigation, and often assists healthcare providers with tech-related transfers.

Competition law boutique Maverick Advocaten N.V. has an established track record in representing mental health care entities, medical device companies, and GPs before the Dutch Healthcare Authority, often in litigation relating to public procurement. Diederik Schrijvershof has a strong focus on healthcare sector mergers and procurement issues, and Martijn van de Hel is well known for advising on state aid issues and investigations by the Netherlands Authority for Consumers and Markets (ACM); the duo co-head the practice with Cyriel Ruers. Annabel Kingma and Leah Peeters are names to note.

Pels Rijcken's team earns plaudits for its 'profound knowledge of the healthcare sector'. The practice is sought after by Dutch governmental entities, healthcare insurance companies and healthcare providers. Practice co-head Wemmeke Wisman is well versed in advising on international public law disputes, often relating to rights to medical treatment, while co-head Marije Batting advises on the reimbursement, approval, and pricing of medicinal products. Co-head Elisabeth Pietermaat is highly regarded for her regulatory expertise.

At Pinsent Masons, the practice is very experienced in advising on IP matters in the life sciences sector. Patent disputes are prominent in the group's workload, and the team has been kept busy assisting pharma and biotech clients with market authorisation matters. Practice head Judith Krens is well versed in advising on multi-jurisdictional SPC and patent litigation, and Arjan Reijns acts on disputes concerning generic product launches.

Under the leadership of Anouk Jagt, the team at Rutgers & Posch is perhaps best known for its strength in advising on professional disciplinary matters and transactional work in the healthcare sector. Dirk Jan Rutgers is a key contact for employment law matters, and Jeanne Plettenburg is very experienced in assisting with procurement and collaborations in the healthcare space.

The team at Taylor Wessing is noted for its expertise in handling UPC issues and infringement actions for clients in the medical device and pharma industries. Regulatory work is another core area of strength for the group. Charlotte Garnitsch is known for her experience in advising on patent infringement proceedings; she co-heads the practice with Eelco Bergsma and Wim Maas. Margot van Gerwen primarily advises pharma companies on trade mark, advertising and copyright issues.